Identification and early intervention for pregnant and postpartum women with substance-use disorders (SUD) are critical for optimizing maternal and neonatal health and wellbeing. The risk factors, common barriers to treatment, evidence-based practices around screening and interventions, and the framework for collaborative strategies to support pregnant and postpartum women with SUD will be discussed.